Sfoglia per AUTORE
BOSA M
Collezione AOU San Luigi di Orbassano
Items : 2
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.
2011
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A;
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. in International journal of hematology / Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.
2009
ASL Città di Torino
AOU San Luigi di Orbassano
ASL Città di Torino
AOU San Luigi di Orbassano
Saglio G; Cilloni D; Morotti A; Allice T; Mete F; Familiari U; Bosa M; Nicoli P; Guerrasio A;